Max Relief Junior

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for use in pediatric patients. Prior to administration, it is essential for healthcare professionals to inquire whether the child is concurrently taking the anticoagulant warfarin, as this may influence the safety and efficacy of the treatment.

There are no teratogenic effects associated with this drug, and no nonteratogenic effects have been reported.

Dosage and Administration

The product must be shaken well before use. Administration should be performed using only the enclosed dosing cup specifically designed for this product.

Dosing should be determined primarily by the patient's weight; however, if weight is not available, age may be used as a secondary guide. The following dosage chart provides the recommended doses:

• For patients weighing under 24 lbs or under 2 years of age, it is advised to consult a doctor before administration.

• For patients weighing 25 to 35 lbs or aged 2 to 3 years, the recommended dose is 1 teaspoon (5 mL).

• For patients weighing 36 to 47 lbs or aged 4 to 5 years, the recommended dose is 1 1/2 teaspoons (7.5 mL).

• For patients weighing 48 to 59 lbs or aged 6 to 8 years, the recommended dose is 2 teaspoons (10 mL).

• For patients weighing 60 to 71 lbs or aged 9 to 10 years, the recommended dose is 2 1/2 teaspoons (12.5 mL).

• For patients weighing 72 to 95 lbs or aged 11 years, the recommended dose is also 2 1/2 teaspoons (12.5 mL).

Healthcare professionals should ensure that the appropriate dose is administered based on the patient's weight or age, as indicated in the chart.

Contraindications

Use of this product is contraindicated in patients who exceed the recommended dose, as this may lead to overdose. No other specific contraindications have been identified.

Warnings and Precautions

Severe liver damage may occur with the use of this product, which contains acetaminophen, if the child exceeds the maximum daily amount of 5 doses within a 24-hour period or if it is taken concurrently with other medications containing acetaminophen.

Acetaminophen has been associated with severe skin reactions, which may manifest as skin reddening, blisters, or rash. In the event of any skin reaction, it is imperative to discontinue use immediately and seek medical assistance.

In cases of severe sore throat that persists for more than 2 days, or if it is accompanied or followed by fever, headache, rash, nausea, or vomiting, prompt consultation with a healthcare provider is advised.

Healthcare professionals should inquire about the child’s medical history, particularly regarding liver disease, prior to recommending this product. Additionally, caution is warranted if the child is concurrently taking the anticoagulant warfarin, as the risk of adverse effects may be heightened. It is essential to adhere to the recommended dosing guidelines to avoid overdose.

In the event of an overdose, immediate medical attention is crucial. Contact the Poison Control Center at 1-800-222-1222 without delay, even if no symptoms are apparent, as rapid intervention can be critical.

Patients should be advised to discontinue use and consult a healthcare provider if pain worsens or persists beyond 5 days, if fever worsens or lasts more than 3 days, or if new symptoms arise, including redness or swelling, as these may indicate a serious underlying condition.

Side Effects

Patients using this product should be aware of several potential adverse reactions, which can range from serious to common.

Severe liver damage is a significant concern associated with the use of this product, particularly due to its acetaminophen content. Patients may be at increased risk if they exceed five doses within a 24-hour period, which is the maximum recommended daily amount, or if they concurrently use other medications containing acetaminophen.

Allergic reactions, particularly severe skin reactions, have been reported. Symptoms may include skin reddening, blisters, and rash. In the event of any skin reaction, patients are advised to discontinue use immediately and seek medical assistance.

Patients should also be vigilant regarding sore throat symptoms. If a sore throat is severe, persists for more than two days, or is accompanied by fever, headache, rash, nausea, or vomiting, it is essential to consult a healthcare provider promptly.

Additionally, patients are advised to stop using the product and consult a doctor if pain worsens or lasts longer than five days, if fever worsens or persists for more than three days, or if new symptoms arise, including redness or swelling, as these may indicate a serious condition.

In cases of overdose, immediate medical attention is crucial. Patients should contact a medical professional or the Poison Control Center (1-800-222-1222) without delay, even if no signs or symptoms are apparent. Quick intervention is critical in such situations.

Drug Interactions

Acetaminophen may interact with the anticoagulant warfarin. It is advisable for patients to consult a healthcare professional, such as a doctor or pharmacist, prior to using acetaminophen if they are concurrently taking warfarin. This precaution is necessary to ensure safe and effective use, as the interaction could potentially affect the anticoagulant's efficacy and safety profile.

No additional drug interactions or laboratory test interactions have been identified for acetaminophen.

Packaging & NDC

Below are the non-prescription pack sizes of Max Relief Junior (children acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 24 lbs (under 2 years) should consult a doctor before use. For children aged 2 to 3 years weighing 25 to 35 lbs, the recommended dosage is 1 teaspoon (5 mL). For those aged 4 to 5 years weighing 36 to 47 lbs, the dosage increases to 1 1/2 teaspoons (7.5 mL). Children aged 6 to 8 years weighing 48 to 59 lbs should receive 2 teaspoons (10 mL), while those aged 9 to 10 years weighing 60 to 71 lbs may take 2 1/2 teaspoons (12.5 mL). For children aged 11 years weighing 72 to 95 lbs, the dosage remains at 2 1/2 teaspoons (12.5 mL).

Severe liver damage may occur if a child exceeds 5 doses in 24 hours, which is the maximum daily amount, or if used concurrently with other medications containing acetaminophen. Acetaminophen may also cause severe skin reactions, including skin reddening, blisters, and rash; if such reactions occur, use should be discontinued immediately, and medical assistance sought. Parents should be vigilant for severe sore throat symptoms that persist for more than 2 days or are accompanied by fever, headache, rash, nausea, or vomiting, and consult a doctor promptly in these cases.

It is crucial to avoid using this medication with any other drug containing acetaminophen, whether prescription or nonprescription. If there is uncertainty regarding the presence of acetaminophen in another medication, consultation with a doctor or pharmacist is advised. Additionally, a healthcare professional should be consulted before use if the child has liver disease or is taking the blood-thinning medication warfarin.

In the event of an overdose, immediate medical help should be sought, or the Poison Control Center (1-800-222-1222) contacted, as prompt medical attention is essential, even if no symptoms are evident. This medication should be stored out of reach of children to prevent accidental ingestion.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

The available prescribing information does not provide specific data regarding the use of this product during pregnancy. Consequently, the safety concerns, dosage modifications, or special precautions for pregnant patients remain undefined. Healthcare professionals should exercise caution when considering this product for women of childbearing potential and weigh the potential risks against the benefits. It is advisable to discuss any potential implications with patients who are pregnant or planning to become pregnant.

Lactation

There are no specific warnings or recommendations regarding nursing mothers. Additionally, there are no specific considerations or precautions mentioned regarding lactation.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment should consult a healthcare professional, such as a doctor or pharmacist, prior to use if they have liver disease. It is essential to assess liver function and consider potential adjustments in dosage or monitoring requirements based on the severity of the hepatic impairment. Careful evaluation is necessary to ensure the safe and effective use of the medication in this population.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance. Healthcare professionals are advised to contact the Poison Control Center at 1-800-222-1222 without delay. Prompt medical intervention is crucial, even in the absence of noticeable signs or symptoms of overdose.

The management of an overdose should be guided by the clinical presentation and the specific circumstances surrounding the incident. Continuous monitoring and supportive care may be necessary, depending on the severity of the symptoms exhibited by the patient. It is essential to remain vigilant for any potential manifestations of toxicity, as these may not be immediately apparent.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified that acetaminophen may be associated with severe skin reactions. Reports indicate that symptoms can include skin reddening, blisters, and rash. In the event of a skin reaction, it is advised to discontinue use immediately and seek medical assistance.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact the Poison Control Center at 1-800-222-1222 in the event of an overdose. It is crucial to emphasize that prompt medical attention is necessary, even if the patient does not exhibit any signs or symptoms of overdose.

Patients should be instructed to discontinue use and consult a healthcare professional if they experience any of the following: worsening pain that persists for more than 5 days, a fever that worsens or lasts longer than 3 days, or the emergence of new symptoms, redness, or swelling. These may indicate a serious underlying condition that requires further evaluation.

Additionally, healthcare providers should remind patients to consult with a doctor or pharmacist prior to use if the child has liver disease. It is also important to discuss the use of this product in conjunction with the blood-thinning medication warfarin, as this may necessitate special consideration. Patients must be cautioned against exceeding the recommended dosage, as this could lead to overdose.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available upon request. It should be stored at room temperature, within the range of 20° to 25°C (68° to 77°F). Care must be taken to protect the product from freezing, as well as from exposure to light to maintain its integrity and efficacy.

Additional Clinical Information

The medication is administered orally. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Max Relief Junior, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)